Passage Bio Stock Options

PASG Stock  USD 5.40  0.16  2.88%   
Passage Bio's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 1.12 with a put-to-call open interest ratio of 0.02 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on September 19th 2025.

Open Interest Against September 19th 2025 Option Contracts

The chart above shows Passage Bio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Passage Bio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Passage Bio's option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Passage Bio

Analyzing Passage Bio's in-the-money options over time can help investors to take a profitable long position in Passage Bio regardless of its overall volatility. This is especially true when Passage Bio's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Passage Bio's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Passage Bio's stock while costing only a fraction of its price.

Passage Bio In The Money Call Balance

When Passage Bio's strike price is surpassing the current stock price, the option contract against Passage Bio stock is said to be in the money. When it comes to buying Passage Bio's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Passage Bio are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Passage Current Options Market Mood

Passage Bio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Passage Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Passage Bio's options investors are not very successful. Passage Bio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Passage contract

Base on the Rule 16, the options market is currently suggesting that Passage Bio will have an average daily up or down price movement of about 0.07% per day over the life of the 2025-09-19 option contract. With Passage Bio trading at USD 5.4, that is roughly USD 0.00378. If you think that the market is fully incorporating Passage Bio's daily price movement you should consider buying Passage Bio options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Passage Bio options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Passage calls. Remember, the seller must deliver Passage Bio stock to the call owner when a call is exercised.

Passage Bio Option Chain

When Passage Bio's strike price is surpassing the current stock price, the option contract against Passage Bio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Passage Bio's option chain is a display of a range of information that helps investors for ways to trade options on Passage. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Passage. It also shows strike prices and maturity days for a Passage Bio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PASG250919C000075001497.50.0 - 0.050.05Out
Call
PASG250919C000050001385.00.0 - 2.252.25In
Call
PASG250919C000025002922.50.0 - 0.10.05In
 Put
PASG250919P0000750007.55.6 - 7.57.3In
 Put
PASG250919P0000500045.03.1 - 5.04.63Out
 Put
PASG250919P0000250072.50.6 - 2.52.07Out

Passage Bio Market Cap Over Time

   Market Cap   
       Timeline  

Passage Total Stockholder Equity

Total Stockholder Equity

58.2 Million

At this time, Passage Bio's Total Stockholder Equity is most likely to increase significantly in the upcoming years.

Passage Bio Corporate Management

Sue BrowneSenior DevelopmentProfile
Simona KingCFO SecProfile
JD EsqGeneral SecretaryProfile
Gregory FuestVice MarketingProfile
MSc MBAChief OfficerProfile
Kathleen BorthwickPrincipal FinanceProfile
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Passage Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(20.40)
Return On Assets
(0.34)
Return On Equity
(0.84)
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.